Mounjaro® 10 mg Injection Pen — Doctor Consultation Included
Mounjaro® is a prescription medicine used as part of a medically supervised weight management programme. It is administered once weekly.
Its active ingredient is tirzepatide, a dual receptor agonist that acts on both GIP — glucose-dependent insulinotropic polypeptide receptors and GLP-1 — glucagon-like peptide-1 receptors. This dual-action mechanism may support weight management and improve insulin sensitivity under medical supervision.
Mounjaro® has been approved by the US Food and Drug Administration — FDA for the treatment of type 2 diabetes and has shown weight management benefits in clinical studies.
This programme requires a consultation with a doctor, who will assess whether Mounjaro® is suitable for you.
- The medication must be used under the guidance of qualified healthcare professionals
- The medication must be prescribed by a doctor
- If required, a nurse may assist with the first injection
- One-to-one registered dietitian consultation is also available to support your weight management plan*














